Subscribe To
Docgo alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against docgo, inc. and encourages investors to contact the firm
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...
November 4, 2023, 1:00 am
R1 rcm alert: bragar eagel & squire, p.c. is investigating r1 rcm corp. on behalf of r1 rcm stockholders and encourages investors to contact the firm
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...
November 4, 2023, 1:00 am
Path final deadline: rosen, national trial lawyers, encourages uipath, inc. investors to secure counsel before important deadline in securities class action – path
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — WHY: Rosen Law Firm, a gl...
November 4, 2023, 1:00 am
The weekly bottom line: the fed’s door is still open
U.S. Highlights The Federal Reserve’s policy statement took center stage this week. As expected, the Fed kept policy rates unchanged but preserved t...
November 4, 2023, 12:36 am
Rosen, a leading law firm, encourages pacwest bancorp investors with losses in excess of $100k to secure counsel before important deadline in securities class action – pacw, pacwp
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — WHY: Rosen Law Firm, a gl...
November 4, 2023, 12:30 am
Investors sue barclays for inaccurately disclosing ex-ceo’s ties to jeffrey epstein – hagens berman
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Barclays PLC (BCS) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fra...
November 4, 2023, 12:22 am
Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLobE NEWSWIRE) — Robbins Ge...
November 4, 2023, 12:13 am
Canon isn't picture-perfect
Canon has operational advantages in its printing segment and has a strong global presence in various ma...
November 4, 2023, 12:12 am
Seacor marine: good company, but not good enough
The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...
November 4, 2023, 12:05 am
South korea's exports rebound in october 2023
South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y in Oct...
November 4, 2023, 12:04 am
Rosen, top ranked investor counsel, encourages tandem diabetes care, inc. investors to secure counsel before important deadline in securities class action – tndm
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — WHY: Rosen Law Firm, a gl...
November 4, 2023, 12:00 am
Regal rexnord corporation (rrx) q3 2023 earnings call transcript
Regal Rexnord Corporation (NYSE:RRX ) Q3 2023 Earnings Conference Call November 2, 2023 10:00 AM ET Company Participants R...
November 3, 2023, 11:54 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...
November 3, 2023, 11:30 pm
Rosen, national trial lawyers, encourages purecycle technologies, inc. investors to secure counsel before important deadline in securities class action – pct, pcttw, pcttu
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — WHY: Rosen Law Firm, a gl...
November 3, 2023, 11:20 pm
Rosen, skilled investor counsel, encourages enviva inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – eva
NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — WHY: Rosen Law Firm, a gl...
November 3, 2023, 11:20 pm
Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl
This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLobE NEWSW...
November 3, 2023, 11:10 pm
Vitesse energy, inc. (vts) q3 2023 earnings call transcript
Vitesse Energy, Inc. (NYSE:VTS ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Ben Messier - Director, IR B...
November 3, 2023, 11:03 pm